CN113444656B - 一种具有抗衰老功能的菌株及其应用 - Google Patents
一种具有抗衰老功能的菌株及其应用 Download PDFInfo
- Publication number
- CN113444656B CN113444656B CN202110448971.2A CN202110448971A CN113444656B CN 113444656 B CN113444656 B CN 113444656B CN 202110448971 A CN202110448971 A CN 202110448971A CN 113444656 B CN113444656 B CN 113444656B
- Authority
- CN
- China
- Prior art keywords
- strain
- aging
- bacillus velezensis
- bacillus
- aging function
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000003712 anti-aging effect Effects 0.000 title claims abstract description 33
- 241000193744 Bacillus amyloliquefaciens Species 0.000 claims abstract description 52
- 230000006870 function Effects 0.000 claims abstract description 27
- 241001465754 Metazoa Species 0.000 claims abstract description 17
- 210000003205 muscle Anatomy 0.000 claims abstract description 15
- 230000001850 reproductive effect Effects 0.000 claims abstract description 13
- 238000004321 preservation Methods 0.000 claims abstract description 10
- 230000002708 enhancing effect Effects 0.000 claims abstract description 8
- 230000001149 cognitive effect Effects 0.000 claims abstract description 4
- 239000003814 drug Substances 0.000 claims description 8
- 238000000855 fermentation Methods 0.000 claims description 8
- 230000004151 fermentation Effects 0.000 claims description 8
- 239000001963 growth medium Substances 0.000 claims description 7
- 244000063299 Bacillus subtilis Species 0.000 claims description 6
- 235000014469 Bacillus subtilis Nutrition 0.000 claims description 6
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 6
- 239000000843 powder Substances 0.000 claims description 6
- 241000193830 Bacillus <bacterium> Species 0.000 claims description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 4
- 239000008103 glucose Substances 0.000 claims description 4
- 229920001817 Agar Polymers 0.000 claims description 3
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 claims description 3
- 239000008272 agar Substances 0.000 claims description 3
- 235000015278 beef Nutrition 0.000 claims description 3
- 229940041514 candida albicans extract Drugs 0.000 claims description 3
- 239000005018 casein Substances 0.000 claims description 3
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims description 3
- 235000021240 caseins Nutrition 0.000 claims description 3
- 229940079593 drug Drugs 0.000 claims description 3
- 239000000284 extract Substances 0.000 claims description 3
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims description 3
- 235000019341 magnesium sulphate Nutrition 0.000 claims description 3
- 229940099596 manganese sulfate Drugs 0.000 claims description 3
- 239000011702 manganese sulphate Substances 0.000 claims description 3
- 235000007079 manganese sulphate Nutrition 0.000 claims description 3
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 claims description 3
- 239000002609 medium Substances 0.000 claims description 3
- 230000000813 microbial effect Effects 0.000 claims description 3
- 229910000402 monopotassium phosphate Inorganic materials 0.000 claims description 3
- 235000019796 monopotassium phosphate Nutrition 0.000 claims description 3
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 claims description 3
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 claims description 3
- 239000001632 sodium acetate Substances 0.000 claims description 3
- 235000017281 sodium acetate Nutrition 0.000 claims description 3
- YWYZEGXAUVWDED-UHFFFAOYSA-N triammonium citrate Chemical compound [NH4+].[NH4+].[NH4+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O YWYZEGXAUVWDED-UHFFFAOYSA-N 0.000 claims description 3
- 239000001393 triammonium citrate Substances 0.000 claims description 3
- 235000011046 triammonium citrate Nutrition 0.000 claims description 3
- 239000012138 yeast extract Substances 0.000 claims description 3
- 230000003647 oxidation Effects 0.000 claims 1
- 238000007254 oxidation reaction Methods 0.000 claims 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims 1
- 229920000053 polysorbate 80 Polymers 0.000 claims 1
- 238000002360 preparation method Methods 0.000 claims 1
- 230000032683 aging Effects 0.000 abstract description 23
- 230000003078 antioxidant effect Effects 0.000 abstract description 8
- 239000003963 antioxidant agent Substances 0.000 abstract description 7
- 244000005700 microbiome Species 0.000 abstract description 5
- 241000699670 Mus sp. Species 0.000 description 29
- 239000003651 drinking water Substances 0.000 description 25
- 235000020188 drinking water Nutrition 0.000 description 25
- 230000000694 effects Effects 0.000 description 25
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 15
- 238000012360 testing method Methods 0.000 description 11
- 241000699666 Mus <mouse, genus> Species 0.000 description 8
- 230000007423 decrease Effects 0.000 description 7
- 239000002504 physiological saline solution Substances 0.000 description 7
- 239000000243 solution Substances 0.000 description 6
- 210000001035 gastrointestinal tract Anatomy 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 210000000813 small intestine Anatomy 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 241000700159 Rattus Species 0.000 description 4
- 241000607142 Salmonella Species 0.000 description 4
- 241000191967 Staphylococcus aureus Species 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 238000009395 breeding Methods 0.000 description 4
- 230000001488 breeding effect Effects 0.000 description 4
- 238000012258 culturing Methods 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 150000003254 radicals Chemical class 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 230000004083 survival effect Effects 0.000 description 4
- 108020004465 16S ribosomal RNA Proteins 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 230000003930 cognitive ability Effects 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 244000005709 gut microbiome Species 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 230000002107 myocardial effect Effects 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 238000012549 training Methods 0.000 description 3
- 241000194103 Bacillus pumilus Species 0.000 description 2
- 102000011632 Caseins Human genes 0.000 description 2
- 108010076119 Caseins Proteins 0.000 description 2
- 241000186660 Lactobacillus Species 0.000 description 2
- WSMYVTOQOOLQHP-UHFFFAOYSA-N Malondialdehyde Chemical compound O=CCC=O WSMYVTOQOOLQHP-UHFFFAOYSA-N 0.000 description 2
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 2
- 241000282887 Suidae Species 0.000 description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
- 230000004075 alteration Effects 0.000 description 2
- 230000003385 bacteriostatic effect Effects 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000000971 hippocampal effect Effects 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 229940039696 lactobacillus Drugs 0.000 description 2
- 229940118019 malondialdehyde Drugs 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 210000002027 skeletal muscle Anatomy 0.000 description 2
- 230000035882 stress Effects 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 2
- 230000003313 weakening effect Effects 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 102000006587 Glutathione peroxidase Human genes 0.000 description 1
- 108700016172 Glutathione peroxidases Proteins 0.000 description 1
- 239000006142 Luria-Bertani Agar Substances 0.000 description 1
- 102000001068 Neural Cell Adhesion Molecules Human genes 0.000 description 1
- 108010069196 Neural Cell Adhesion Molecules Proteins 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 102000019197 Superoxide Dismutase Human genes 0.000 description 1
- 108010012715 Superoxide dismutase Proteins 0.000 description 1
- 229940124350 antibacterial drug Drugs 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000019771 cognition Effects 0.000 description 1
- 208000010877 cognitive disease Diseases 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000003412 degenerative effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000000550 effect on aging Effects 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 230000002431 foraging effect Effects 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000000745 gonadal hormone Substances 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 230000003832 immune regulation Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 230000007087 memory ability Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- XZWYZXLIPXDOLR-UHFFFAOYSA-N metformin Chemical compound CN(C)C(=N)NC(N)=N XZWYZXLIPXDOLR-UHFFFAOYSA-N 0.000 description 1
- 229960003105 metformin Drugs 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 210000004789 organ system Anatomy 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 229960003387 progesterone Drugs 0.000 description 1
- 239000000186 progesterone Substances 0.000 description 1
- 230000007111 proteostasis Effects 0.000 description 1
- 230000008844 regulatory mechanism Effects 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000011218 seed culture Methods 0.000 description 1
- 210000002863 seminiferous tubule Anatomy 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 210000002363 skeletal muscle cell Anatomy 0.000 description 1
- 210000001324 spliceosome Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 229960003604 testosterone Drugs 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
- A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Polymers & Plastics (AREA)
- Neurology (AREA)
- Mycology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Food Science & Technology (AREA)
- Molecular Biology (AREA)
- Neurosurgery (AREA)
- Reproductive Health (AREA)
- Nutrition Science (AREA)
- Hospice & Palliative Care (AREA)
- Toxicology (AREA)
- Psychiatry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Biotechnology (AREA)
- Physiology (AREA)
- Animal Husbandry (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110448971.2A CN113444656B (zh) | 2021-04-25 | 2021-04-25 | 一种具有抗衰老功能的菌株及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110448971.2A CN113444656B (zh) | 2021-04-25 | 2021-04-25 | 一种具有抗衰老功能的菌株及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113444656A CN113444656A (zh) | 2021-09-28 |
CN113444656B true CN113444656B (zh) | 2022-07-22 |
Family
ID=77809552
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110448971.2A Active CN113444656B (zh) | 2021-04-25 | 2021-04-25 | 一种具有抗衰老功能的菌株及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113444656B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115093998B (zh) * | 2022-06-24 | 2023-10-17 | 华南农业大学 | 一种用于发酵豆粕的贝莱斯芽孢杆菌 |
CN115466693B (zh) * | 2022-08-17 | 2023-12-05 | 华南农业大学 | 一株斯塔贝基斯鲁梅利杆菌cy2菌株及其应用 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101960355B1 (ko) * | 2018-01-23 | 2019-03-20 | 재단법인 발효미생물산업진흥원 | 항균활성, 항산화활성, 세포외 효소 분비능 및 페놀 생성능이 있고, 유해물질 및 유해효소를 생성하지 않는 바실러스 벨레젠시스 srcm102755 균주 및 이의 용도 |
CN110982760A (zh) * | 2019-12-31 | 2020-04-10 | 云南省畜牧兽医科学院 | 一株贝莱斯芽孢杆菌及其在防治猪腹泻中的应用 |
CN111676156A (zh) * | 2020-06-03 | 2020-09-18 | 青岛农业大学 | 一株提高还原活性的贝莱斯芽孢杆菌mrs及其发酵物和应用 |
CN111961629A (zh) * | 2020-08-28 | 2020-11-20 | 山东省果树研究所 | 一种樱桃防腐保鲜微生物制剂及其制备方法与应用 |
-
2021
- 2021-04-25 CN CN202110448971.2A patent/CN113444656B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101960355B1 (ko) * | 2018-01-23 | 2019-03-20 | 재단법인 발효미생물산업진흥원 | 항균활성, 항산화활성, 세포외 효소 분비능 및 페놀 생성능이 있고, 유해물질 및 유해효소를 생성하지 않는 바실러스 벨레젠시스 srcm102755 균주 및 이의 용도 |
CN110982760A (zh) * | 2019-12-31 | 2020-04-10 | 云南省畜牧兽医科学院 | 一株贝莱斯芽孢杆菌及其在防治猪腹泻中的应用 |
CN111676156A (zh) * | 2020-06-03 | 2020-09-18 | 青岛农业大学 | 一株提高还原活性的贝莱斯芽孢杆菌mrs及其发酵物和应用 |
CN111961629A (zh) * | 2020-08-28 | 2020-11-20 | 山东省果树研究所 | 一种樱桃防腐保鲜微生物制剂及其制备方法与应用 |
Non-Patent Citations (1)
Title |
---|
Bacillus velezensis A2 fermentation exerts a protective effect on renal injury induced by Zearalenone in mice;Nan Wang et al.;《Scientific Reports》;20180911;第8卷(第1期);摘要,第1页第1段至第11页最后1段,图8 * |
Also Published As
Publication number | Publication date |
---|---|
CN113444656A (zh) | 2021-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110835616B (zh) | 副干酪乳杆菌gks6的活性物质、含其的组合物及其促进长寿的用途 | |
CN104560820B (zh) | 屎肠球菌kq2.6及应用 | |
CN104630083B (zh) | 一种卷曲乳杆菌及其在妇女保健产品中的应用 | |
CN113088463B (zh) | 一种具有益生特性的嗜酸乳杆菌及其应用 | |
CN110577912B (zh) | 一种格氏乳杆菌及其在制备发酵乳中的应用 | |
CN113444656B (zh) | 一种具有抗衰老功能的菌株及其应用 | |
CN110157645B (zh) | 一种唾液乳杆菌y4及其应用 | |
Schneedorf | Kefir D’Aqua and its probiotic properties | |
CN114642686B (zh) | 一种复合益生菌及其延缓衰老和抗氧化的作用 | |
CN114134083B (zh) | 一种贝莱斯芽孢杆菌及应用 | |
CN110833565B (zh) | 植物乳杆菌gkm3的活性物质、含其的组合物及其促进长寿的用途 | |
CN115322932B (zh) | 一株具有解酒醒酒能力的植物乳植杆菌和应用 | |
CN109182162A (zh) | 一株具有抗氧化能力的植物乳杆菌及应用 | |
CN116077415B (zh) | 一种用于调节皮肤微生态平衡的三元益生因子组合物 | |
CN107227269B (zh) | 具有头孢抗性且高表达Sir2蛋白的嗜酸乳杆菌及其应用 | |
CN115637240A (zh) | 一种贝莱斯芽孢杆菌及其应用 | |
CN110835615A (zh) | 乳双歧杆菌gkk2的活性物质、含其的组合物及其促进长寿的用途 | |
KR101098946B1 (ko) | 신규한 락토바실러스 살리바리우스 균주 및 이를 함유하는 사료첨가제 조성물 | |
CN117210350A (zh) | 一种乳酸片球菌及应用 | |
CN116790431A (zh) | 能够缓解便秘与腹泻的婴儿源动物双歧杆菌乳亚种、微生物菌剂及其应用 | |
CN110141584A (zh) | 一种开菲尔乳杆菌m11在抑菌及作为治疗ⅱ型糖尿病药剂的活性成分的应用 | |
CN102994416A (zh) | 一株犬源地衣芽孢杆菌y10及其应用 | |
CN110141583A (zh) | 一种开菲尔乳杆菌m3在抑菌及作为治疗ⅱ型糖尿病药剂的活性成分的应用 | |
CN109971667A (zh) | 一株猪源植物乳杆菌及应用 | |
RU2694256C2 (ru) | Кормовая добавка для профилактики бактерионосительства микроорганизмов рода Salmonella у сельскохозяйственной птицы и способ ее применения |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240724 Address after: 230051 Room 802, building C, QingWang Science Park, Baohe Economic Development Zone, Hefei City, Anhui Province Patentee after: Hefei xingzhicheng Information Technology Co.,Ltd. Country or region after: China Address before: 510642 No. five, 483 mountain road, Guangzhou, Guangdong, Tianhe District Patentee before: SOUTH CHINA AGRICULTURAL University Country or region before: China |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240730 Address after: No. 105-5, Xiong'an Chenqi Entrepreneurship Incubation Base, Bus Station, East Side of Yililan Avenue, Anxin County, Baoding City, Hebei Province, 071800 Patentee after: Hebei xiongan bioscience Co.,Ltd. Country or region after: China Address before: 230051 Room 802, building C, QingWang Science Park, Baohe Economic Development Zone, Hefei City, Anhui Province Patentee before: Hefei xingzhicheng Information Technology Co.,Ltd. Country or region before: China |
|
TR01 | Transfer of patent right |